ANGLE plc (OTCMKTS:ANPCY – Get Free Report) was the recipient of a significant drop in short interest during the month of December. As of December 15th, there was short interest totaling 2,799 shares, a drop of 94.5% from the November 30th total of 50,523 shares. Based on an average daily trading volume, of 28,223 shares, the short-interest ratio is presently 0.1 days. Based on an average daily trading volume, of 28,223 shares, the short-interest ratio is presently 0.1 days.
ANGLE Stock Performance
Shares of OTCMKTS ANPCY opened at C$0.07 on Thursday. The firm has a 50 day moving average price of C$0.19 and a 200 day moving average price of C$0.52. ANGLE has a 52-week low of C$0.07 and a 52-week high of C$2.39.
About ANGLE
ANGLE plc is a United Kingdom–based biotechnology company specializing in the development and commercialization of liquid biopsy technologies for the capture and analysis of rare cells. The company’s principal offering, the Parsortix system, employs proprietary microfluidic instrumentation to isolate circulating tumor cells (CTCs) and other rare cell populations from blood samples without the need for labels. This platform is designed for both research and clinical applications, enabling downstream molecular and cellular analyses that support cancer diagnostics, prognostics and therapy monitoring.
ANGLE’s product portfolio comprises the Parsortix Harvest system and single-use cassettes, along with associated reagents and software for cell capture, imaging and data management.
Featured Stories
- Five stocks we like better than ANGLE
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Forget AI, This Will Be the Next Big Tech Breakthrough
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
